The mesenchymal–epithelial transition (MET) gene encodes the MET receptor, a tyrosine kinase that drives key processes in cancer, including cell growth, survival, migration, and invasion by activating signal transduction pathways, including the RAS-MAPK cascade, PI3K-AKT pathway, and STAT pathways. Here, MET is linked to cancer.